Antisense inhibition of acetylcholinesterase gene expression for treating cognition deficit in Alzheimer's disease model mice

Brain Research

Volumn 1066, Issue 1-2, 2005, Pages 10-15

  Fu, Ai Ling ^a,b   Zhang, Xing Mei ^c   Sun, Man Ji ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

^c Nanfang Medical University   (China)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Amyloid peptide; Antisense oligodeoxynucleotide

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; LEARNING; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; SWIMMING;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; COGNITION DISORDERS; CONDITIONING, OPERANT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; MALE; MAZE LEARNING; MEMORY; MICE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;

ANIMALIA;

EID: 29044448249     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.09.063     Document Type: Article

References (22)

1. S. Agrawal, and E.R. Kandimalla Antisense and siRNA as agonists of Toll-like receptors Nat. Biotechnol. 22 2004 1533 1537
2. A. Alvarez, R. Alarcon, C. Opazo, E.O. Campos, F.J. Munoz, and F.H. Calseron Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils J. Neurosci. 18 1998 3213 3223
3. D.S. Auld, T.J. Kornecook, S. Bastianetto, and R. Quirion Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies Prog. Neurobiol. 68 2002 209 245
4. B.J. Cummings, C.J. Pike, R. Shankle, and C.W. Cotman Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease Neurobiol. Aging 17 1996 921 933
5. G.L. Ellman, K.D. Courtney, V. Andrews Jr., and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
6. A.L. Fu, S.J. Huang, and M.J. Sun Complementary remedy of aged-related learning and memory deficits via exogenous choline acetyltransferase Biochem. Biophys. Res. Commun. 336 2005 268 273
7. N.C. Inestrosa, A. Alvarez, C.A. Perez, R.D. Moreno, M. Vicente, C. Linker, O.I. Casanueva, C. Soto, and J. Garrido Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme Neuron 16 1996 881 891
8. N.C. Inestrosa, J.P. Sagal, and M. Colombres Acetylcholinesterase interaction with Alzheimer amyloid beta Sub-cell. Biochem. 38 2005 299 317
9. S. Kar, S.P. Slowikowski, D. Westaway, and H.T. Mount Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease J. Psychiatry Neurosci. 29 2004 427 441
10. P. Kienlen-Campard, and J.N. Octave Correlation between beta-amyloid peptide production and human APP-induced neuronal death Peptides 23 2002 1199 1204
11. R.M. Lane, M. Kivipelto, and N.H. Greig Acetylcholinesterase and its inhibition in Alzheimer disease Clin. Neuropharmacol. 27 2004 141 149
12. S.E. Laursen, and J.K. Belknap Intracerebroventricular injections in mice. Some methodological refinements J. Pharmacol. Methods 16 1986 355 357
13. Y. Loewenstein-Lichtenstein, M. Schwarz, D. Glick, B. Norgaard-Pedersen, H. Zakut, and H. Soreq Genetic predisposition to adverse consequences of auto-cholinesterase in "atypical" BCHE carriers Nat. Med. 1 1995 1082 1085
14. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
15. T. Maurice, B.P. Lockhart, and A. Privat Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction Brain Res. 706 1996 181 193
16. K.M. Mehta, M. Yin, C. Resendez, and K. Yaffe Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease Neurology 65 2005 159 162
17. E. Meshorer, C. Erb, R. Gazit, L. Pavlovsky, D. Kaufer, and A. Friedman Alternative splicing and neuritis mRNA translocation under long term neuronal hypersensitive Science 295 2002 508 512
18. F. Misiti, G.E. Martorana, G. Nocca, E. Di Stasio, B. Giardina, and M.E. Clementi Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid beta-protein fragment (31-35) on isolated brain mitochondria Neuroscience 126 2004 297 303
19. T. Takadera, N. Sakura, T. Mohri, and T. Hashimoto Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention Neurosci. Lett. 161 1993 41 44
20. V.N. Talesa Acetylcholinesterase in Alzheimer's disease Mech. Ageing Dev. 122 2001 1961 1969
21. X.M. Zhang, G. Liu, and M.J. Sun Epitopes of human brain acetylcholinesterase Brain Res. 868 2000 157 164
22. M.C. Zhu, Y.B. Xin, M.J. Sun, and Y.Z. Fang Purification and properties of acetylcholinesterase from human brain Sci. China 36 1993 1209 1215